Network pharmacology-based prediction of the active ingredients and potential targets of Mahuang Fuzi Xixin decoction for application to allergic rhinitis

Journal of Ethnopharmacology

Volumn 176, Issue , 2015, Pages 402-412

  Tang, Feng ^a   Tang, Qingfa ^a   Tian, Yuanxin ^a   Fan, Qin ^a   Huang, Yao ^a   Tan, Xiaomei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Allergic rhinitis; Mahuang Fuzi Xixin Decoction; Network pharmacology; Traditional Chinese Medicine

Indexed keywords

7 HYDROXY 3 (2,3,4 TRIMETHOXYPHENYL)CHROMAN 4 ONE; ANTIINFLAMMATORY AGENT; APIGENIN; ARACHIDONATE 5 LIPOXYGENASE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CHINESE DRUG; DIPEPTIDYL PEPTIDASE IV; EPHEDRINE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 90; HERBACETIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; KAEMPFEROL; LUTEOLIN; MAHUANG FUZI XIXIN DECOCTION; METHYLEUGENOL; PHTHALIC ACID DIBUTYL ESTER; PLANT MEDICINAL PRODUCT; PSEUDOEPHEDRINE; QUERCETIN; RUTOSIDE; SALSOLINOL; SITOSTEROL; UNCLASSIFIED DRUG; HERBACEOUS AGENT; MAHUANG FUZI XIXIN; PROSTAGLANDIN E2;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHINESE MEDICINE; DRUG BIOAVAILABILITY; DRUG STRUCTURE; HERBAL MEDICINE; HUMAN; IMMUNOMODULATION; PREDICTION; PROTEIN TARGETING; THERAPY EFFECT; ANIMAL; BIOAVAILABILITY; BIOLOGICAL MODEL; METABOLISM; ORAL DRUG ADMINISTRATION; PHARMACOLOGY; PROCEDURES; RAT; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL AVAILABILITY; CELL LINE, TUMOR; DINOPROSTONE; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; MODELS, BIOLOGICAL; PHARMACOLOGY; RATS; RHINITIS, ALLERGIC;

EID: 84948165405     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2015.10.040     Document Type: Article

References (54)

1. R. Andraws, P. Chawla, and D.L. Brown Cardiovascular effects of ephedra alkaloids: a comprehensive review Prog. Cardiovasc. Dis. 47 2005 217 225
2. K.M. Blechman, S.B. Karch, and B.G. Stephens Demographic, pathologic, and toxicological profiles of 127 decedents testing positive for ephedrine alkaloids Forensic Sci. Int. 139 2004 61 69
3. G.W. Canonica, J. Bousquet, J. Mullol, G.K. Scadding, and J.C. Virchow A survey of the burden of allergic rhinitis in Europe Allergy 62 Suppl 85 2007 17 25
4. P. Chacon, A. Vega, J. Monteseirin, R. El Bekay, G. Alba, J.L. Perez-Formoso, A. Msartinez, J.A. Asturias, R. Perez-Cano, F. Sobrino, and J. Conde Induction of cyclooxygenase-2 expression by allergens in lymphocytes from allergic patients Eur. J. Immunol. 35 2005 2313 2324
5. G.G. Chen, J.F. Lee, S.H. Wang, U.P. Chan, P.C. Ip, and W.Y. Lau Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer Life Sci. 70 2002 2631 2646
6. M. Funaba, T. Ikeda, and M. Abe Degranulation in RBL-2H3 cells: regulation by calmodulin pathway Cell. Biol. Int. 27 2003 879 885
7. C.D. Funk Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294 2001 1871 1875
8. S. Ghosh, M.J. May, and E.B. Kopp NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses Annu. Rev. Immunol. 16 1998 225 260
9. J. Gu, H. Zhang, L. Chen, S. Xu, G. Yuan, and X. Xu Drug-target network and polypharmacology studies of a traditional Chinese medicine for type II diabetes mellitus Comput. Biol. Chem. 35 2011 293 297
10. M. Hamalainen, R. Nieminen, P. Vuorela, M. Heinonen, and E. Moilanen Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages Mediat. Inflamm. 2007 2007 45673
11. S. Hasan, B.K. Bonde, N.S. Buchan, and M.D. Hall Network analysis has diverse roles in drug discovery Drug Discov. today 17 2012 869 874
12. K. Hashimoto, T. Yanagisawa, Y. Okui, Y. Ikeya, M. Maruno, and T. Fujita Studies on anti-allergic components in the roots of Asiasarum sieboldi Planta Medica 60 1994 124 127
13. H. Hikino, C. Konno, H. Takata, and M. Tamada Antiinflammatory principle of Ephedra Herbs Chem. Pharm. Bull. 28 1980 2900 2904
14. H. Hikino, C. Konno, H. Takata, Y. Yamada, C. Yamada, Y. Ohizumi, K. Sugio, and H. Fujimura Antiinflammatory principles of Aconitum roots J. Pharmacobio-Dyn. 3 1980 514 525
15. K.P. Hoeflich, J. Luo, E.A. Rubie, M.S. Tsao, O. Jin, and J.R. Woodgett Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation Nature 406 2000 86 90
16. C.L. Hsieh, G.C. Yen, and H.Y. Chen Antioxidant activities of phenolic acids on ultraviolet radiation-induced erythrocyte and low density lipoprotein oxidation J. Agric. Food Chem. 53 2005 6151 6155
17. Z. Ikawati, S. Wahyuono, and K. Maeyama Screening of several Indonesian medicinal plants for their inhibitory effect on histamine release from RBL-2H3 cells J. Ethnopharmacol. 75 2001 249 256
18. Y. Ikeda, O.T. Iijima, A. Iizuka, A. Ishige, S. Amagaya, Y. Komatsu, M. Okada, C. Abe, and E. Fujihira Anti-inflammatory effects of mao-bushi-saishin-to in mice and rats Am. J. Chin. Med. 26 1998 171 179
19. Y. Ikeda, A. Iizuka, S. Amagaya, A. Ishige, Y. Komatsu, and E. Fujihira Anti-type I allergic mechanisms of mao-bushi-saishin-to in mice Jpn. J. Pharmacol. 82 2000 29 33
20. O.H. Kang, J.G. Choi, J.H. Lee, and D.Y. Kwon Luteolin isolated from the flowers of Lonicera japonica suppresses inflammatory mediator release by blocking NF-kappaB and MAPKs activation pathways in HMC-1 cells Molecules 15 2010 385 398
21. M.C. Kim, D.S. Kim, S.J. Kim, J. Park, H.L. Kim, S.Y. Kim, K.S. Ahn, H.J. Jang, S.G. Lee, K.M. Lee, S.H. Hong, and J.Y. Um Eucommiae cortex inhibits TNF-alpha and IL-6 through the suppression of caspase-1 in lipopolysaccharide-stimulated mouse peritoneal macrophages Am. J. Chin. Med. 40 2012 135 149
22. N. Koshikawa, S. Hasegawa, Y. Nagashima, K. Mitsuhashi, Y. Tsubota, S. Miyata, Y. Miyagi, H. Yasumitsu, and K. Miyazaki Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse Am. J. Pathol. 153 1998 937 944
23. A.K. Leung, and K.L. Hon Seasonal allergic rhinitis Recent Pat. Inflamm. Allergy Drug. Discov. 2 2008 175 185
24. B. Li, X. Xu, X. Wang, H. Yu, X. Li, W. Tao, Y. Wang, and L. Yang A systems biology approach to understanding the mechanisms of action of chinese herbs for treatment of cardiovascular disease Int. J. Mol. Sci. 13 2012 13501 13520
25. H. Li, L. Zhao, B. Zhang, Y. Jiang, X. Wang, Y. Guo, H. Liu, S. Li, and X. Tong A network pharmacology approach to determine active compounds and action mechanisms of ge-gen-qin-lian decoction for treatment of type 2 diabetes Evid.-based Complement. Altern. Med. 2014 2014 495840
26. J. Li, and B. Zhang Apigenin protects ovalbumin-induced asthma through the regulation of Th17 cells Fitoterapia 91 2013 298 304
27. S. Li, B. Zhang, D. Jiang, Y. Wei, and N. Zhang Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae BMC Bioinforma. 11 Suppl. 11 2010 S6
28. X. Li, X. Xu, J. Wang, H. Yu, X. Wang, H. Yang, H. Xu, S. Tang, Y. Li, L. Yang, L. Huang, Y. Wang, and S. Yang A system-level investigation into the mechanisms of Chinese traditional medicine: compound Danshen formula for cardiovascular disease treatment PLoS One 7 2012 e43918
29. X. Liang, H. Li, and S. Li A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study Mol. Biosyst. 10 2014 1014 1022
30. H. Liu, J. Wang, W. Zhou, Y. Wang, and L. Yang Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice J. Ethnopharmacol. 146 2013 773 793
31. Z.H. Liu, and X.B. Sun [Network pharmacology: new opportunity for the modernization of traditional Chinese medicine] Yao xue xue bao (Acta Pharm. Sin.) 47 2012 696 703
32. J.J. Moreno Effect of olive oil minor components on oxidative stress and arachidonic acid mobilization and metabolism by macrophages RAW 264.7 Free. Radic. Biol. Med. 35 2003 1073 1081
33. A. Navarro, B. De las Heras, and A. Villar Anti-inflammatory and immunomodulating properties of a sterol fraction from Sideritis foetens Clem. Biol. Pharm. Bull. 24 2001 470 473
34. E. Ortega, R. Schweitzer-Stenner, and I. Pecht Possible orientational constraints determine secretory signals induced by aggregation of IgE receptors on mast cells EMBO J. 7 1988 4101 4109
35. F. Pellati, and S. Benvenuti Determination of ephedrine alkaloids in Ephedra natural products using HPLC on a pentafluorophenylpropyl stationary phase J. Pharm. Biomed. Anal. 48 2008 254 263
36. Z. Qiusheng, S. Xiling, S. Xubo, Meng, and W. Changhai Protective effects of luteolin-7-glucoside against liver injury caused by carbon tetrachloride in rats Die Pharm. 59 2004 286 289
37. J. Ru, P. Li, J. Wang, W. Zhou, B. Li, C. Huang, P. Li, Z. Guo, W. Tao, Y. Yang, X. Xu, Y. Li, Y. Wang, and L. Yang TCMSP: a database of systems pharmacology for drug discovery from herbal medicines J. Chem. 6 2014 13
38. M. Schatz A survey of the burden of allergic rhinitis in the USA Allergy 62 Suppl. 85 2007 S9 S16
39. W.F. Schoenwetter, L. Dupclay Jr., S. Appajosyula, M.F. Botteman, and C.L. Pashos Economic impact and quality-of-life burden of allergic rhinitis Curr. Med. Res. Opin. 20 2004 305 317
40. R. Taha, R. Olivenstein, T. Utsumi, P. Ernst, P.J. Barnes, I.W. Rodger, and A. Giaid Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 161 2000 636 640
41. T. Takagi, C. Ramachandran, M. Bermejo, S. Yamashita, L.X. Yu, and G.L. Amidon A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan Mol. Pharm. 3 2006 631 643
42. F. Tang, F. Chen, X. Ling, Y. Huang, X. Zheng, Q. Tang, and X. Tan Inhibitory Effect of Methyleugenol on IgE-Mediated Allergic Inflammation in RBL-2H3 Cells Mediat. Inflamm. 2015 2015 1 9
43. W. Tao, X. Xu, X. Wang, B. Li, Y. Wang, Y. Li, and L. Yang Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease J. Ethnopharmacol. 145 2013 1 10
44. T.C. van der Pouw Kraan, L.C. Boeije, R.J. Smeenk, J. Wijdenes, and L.A. Aarden Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production J. Exp. Med. 181 1995 775 779
45. W.P. Walters, and M.A. Murcko Prediction of 'drug-likeness' Adv. Drug Deliv. Rev. 54 2002 255 271
46. X. Wang, X. Xu, Y. Li, X. Li, W. Tao, B. Li, Y. Wang, and L. Yang Systems pharmacology uncovers Janus functions of botanical drugs: activation of host defense system and inhibition of influenza virus replication Integr. Biol.: Quant. Biosci. Nano Macro 5 2013 351 371
47. O. Werz, and D. Steinhilber Therapeutic options for 5-lipoxygenase inhibitors Pharmacol. Ther. 112 2006 701 718
48. X. Xu, W. Zhang, C. Huang, Y. Li, H. Yu, Y. Wang, J. Duan, and Y. Ling A novel chemometric method for the prediction of human oral bioavailability Int. J. Mol. Sci. 13 2012 6964 6982
49. Y. Yamanishi, M. Kotera, M. Kanehisa, and S. Goto Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics 26 2010 Oxford England i246 i254
50. S. Yang, H. Chen, Y. Lin, and Y. Chen The exploration of disease pattern, zheng, for differentiation of allergic rhinitis in traditional chinese medicine practice Evid.-Based Complement. Altern. Med. 2012 2012 521780
51. H.R. Yen, K.L. Liang, T.P. Huang, J.Y. Fan, T.T. Chang, and M.F. Sun Characteristics of traditional Chinese medicine use for children with allergic rhinitis: a nationwide population-based study Int. J. Pediatr. Otorhinolaryngol. 79 2015 591 597
52. H. Yu, J. Chen, X. Xu, Y. Li, H. Zhao, Y. Fang, X. Li, W. Zhou, W. Wang, and Y. Wang A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data PLoS One 7 2012 e37608
53. F. Zhao, L. Guochun, Y. Yang, L. Shi, L. Xu, and L. Yin A network pharmacology approach to determine active ingredients and rationality of herb combinations of Modified-Simiaowan for treatment of gout J. Ethnopharmacol. 168 2015 1 16
54. Y. Zhao, L. Yang, X. Wang, and Z. Zhou The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes Diabetes/Metab. Res. Rev. 30 2014 646 653